The good, the bad, the ugly...6 Oct 2022 17:21
Well, all the above descriptions can apply to the H1 2022 Half year accounts.
The good is growing Sales from organic and from adding new companies.
And this seems to produce good margins and happy clients. Great.
The bad is WHEN will S4 stop purchasing companies because it is destroying declaration of PROFIT and DIVIDEND. It is OK for us to believe in S4's future, but Fund Managers wish to see evidence before investing millions.
The ugly is manana (manyana, always tomorrow) on financials.
The ugly is to reduce debt and avoid another Half Year of '£55million reduction in cash position'.
The company is heavily dependant on an outstanding Q3 and Q4 which was promised.
But will we see Q3 results? A good business late Oct to early Nov. This business, not at all.
Based on the 2022 H1 Report of late September 2022, we will not be seeing any more accounts from S4 until late March 2023!
S4 does not seem to produce meaningful separate Q1 and Q3 Reports.
It is a long time to wait for evidence that debt is reducing, cash is rising, growth is being sustained, and bottom line profits are good and positive.
Large investors want to see the good, the good and the good. No bad, no ugly.
So, when?